Publications by authors named "Dendooven P"

.N, having a half-life of 11 ms, is a highly effective positron emitter that can potentially provide near real-time feedback in proton therapy. There is currently no framework for comparing and validating positron emission imaging ofN.

View Article and Find Full Text PDF

. Proton therapy currently faces challenges from clinical complications on organs-at-risk due to range uncertainties. To address this issue, positron emission tomography (PET) of the proton-inducedC andO activity has been used to provide feedback on the proton range.

View Article and Find Full Text PDF

Hadron therapy is a radiotherapy modality which offers a precise energy deposition to the tumors and a dose reduction to healthy tissue as compared to conventional methods. However, methods for real-time monitoring are required to ensure that the radiation dose is deposited on the target. The IRIS group of IFIC-Valencia developed a Compton camera prototype for this purpose, intending to image the Prompt Gammas emitted by the tissue during irradiation.

View Article and Find Full Text PDF

Early warning networks are used for detecting abnormal radioactivity levels in the environment. State-of-the-art networks are equipped with both dose rate detectors and spectrometric stations. Current networks don't automatically discriminate between radioactivity on the ground and in the air.

View Article and Find Full Text PDF

A fast and reliable range monitoring method is required to take full advantage of the high linear energy transfer provided by therapeutic ion beams like carbon and oxygen while minimizing damage to healthy tissue due to range uncertainties. Quasi-real-time range monitoring using in-beam positron emission tomography (PET) with therapeutic beams of positron-emitters of carbon and oxygen is a promising approach. The number of implanted ions and the time required for an unambiguous range verification are decisive factors for choosing a candidate isotope.

View Article and Find Full Text PDF

A first-of-a-kind geological repository for spent nuclear fuel is being built in Finland and will soon start operations. To make sure all nuclear material stays in peaceful use, the fuel is measured with two complementary non-destructive methods to verify the integrity and the fissile content of the fuel prior to disposal. For pin-wise identification of active fuel material, a Passive Gamma Emission Tomography (PGET) device is used.

View Article and Find Full Text PDF

. Beams of stable ions have been a well-established tool for radiotherapy for many decades. In the case of ion beam therapy with stableC ions, the positron emittersC are produced via projectile and target fragmentation, and their decays enable visualization of the beam via positron emission tomography (PET).

View Article and Find Full Text PDF

Owing to the favorable depth-dose distribution and the radiobiological properties of heavy ion radiation, ion beam therapy shows an improved success/toxicity ratio compared to conventional radiotherapy. The sharp dose gradients and very high doses in the Bragg peak region, which represent the larger physical advantage of ion beam therapy, make it also extremely sensitive to range uncertainties. The use of -radioactive ion beams would be ideal for simultaneous treatment and accurate online range monitoring through PET imaging.

View Article and Find Full Text PDF

Reliable non-destructive methods for verifying spent nuclear fuel are essential to draw credible nuclear safeguards conclusions from spent fuel. In Finland, spent fuel items are verified prior to the soon starting disposal in a geological repository with Passive Gamma Emission Tomography (PGET), a uniquely accurate method capable of rod-level detection of missing active material. The PGET device consists of two highly collimated detector banks, collecting gamma emission data from a 360° rotation around a fuel assembly.

View Article and Find Full Text PDF

Several techniques are under development for image-guidance in particle therapy. Positron (β) emission tomography (PET) is in use since many years, because accelerated ions generate positron-emitting isotopes by nuclear fragmentation in the human body. In heavy ion therapy, a major part of the PET signals is produced by β-emitters generated projectile fragmentation.

View Article and Find Full Text PDF

The applicability extent of hadron therapy for tumor treatment is currently limited by the lack of reliable online monitoring techniques. An active topic of investigation is the research of monitoring systems based on the detection of secondary radiation produced during treatment. MACACO, a multi-layer Compton camera based on LaBr scintillator crystals and SiPMs, is being developed at IFIC-Valencia for this purpose.

View Article and Find Full Text PDF
Article Synopsis
  • Proton therapy provides a more targeted dose to tumors while reducing radiation exposure to surrounding tissues compared to traditional photon therapy.
  • Quality assurance methods like positron emission tomography (PET) are being adapted to verify the proton range in near real time, allowing for quicker corrections to any discrepancies in dose delivery.
  • The study demonstrated a novel approach to PET imaging that successfully tracked activity during proton irradiation, achieving precise measurements of radiation range with a low standard deviation across multiple tests.
View Article and Find Full Text PDF

Therapy with helium ions is currently receiving significantly increasing interest because helium ions have a sharper penumbra than protons and undergo less fragmentation than carbon ions and thus require less complicated dose calculations. For any ion of interest in hadron therapy, the accuracy of dose delivery is limited by range uncertainties. This has led to efforts by several groups to develop in vivo verification techniques, including positron emission tomography (PET), for monitoring of the dose delivery.

View Article and Find Full Text PDF

A thin 5-mm NaI(Tl) scintillator detector was tested with the goal of enhancing the detection efficiency of Am gamma and X rays for steelworks operations. The performance of a thin (5 mm) NaI(Tl) detector was compared with a standard 76.2-mm thick NaI(Tl) detector.

View Article and Find Full Text PDF

The most common explosives can be uniquely identified by measuring the elemental H/N ratio with a precision better than 10%. Monte Carlo simulations were used to design two variants of a new prompt gamma neutron activation instrument that can achieve this precision. The instrument features an intense pulsed neutron generator with precise timing.

View Article and Find Full Text PDF

In vivo dose delivery verification in proton therapy can be performed by positron emission tomography (PET) of the positron-emitting nuclei produced by the proton beam in the patient. A PET scanner installed in the treatment position of a proton therapy facility that takes data with the beam on will see very short-lived nuclides as well as longer-lived nuclides. The most important short-lived nuclide for proton therapy is N (Dendooven et al 2015 Phys.

View Article and Find Full Text PDF

In order to exploit the advantages of ion-beam therapy in a clinical setting, delivery verification techniques are necessary to detect deviations from the planned treatment. Efforts are currently oriented towards the development of devices for real-time range monitoring. Among the different detector concepts proposed, Compton cameras are employed to detect prompt gammas and represent a valid candidate for real-time range verification.

View Article and Find Full Text PDF

The only method for in vivo dose delivery verification in proton beam radiotherapy in clinical use today is positron emission tomography (PET) of the positron emitters produced in the patient during irradiation. PET imaging while the beam is on (so called beam-on PET) is an attractive option, providing the largest number of counts, the least biological washout and the fastest feedback. In this implementation, all nuclides, independent of their half-life, will contribute.

View Article and Find Full Text PDF

Irradiation with protons and light ions offers new possibilities for tumor therapy but has a strong need for novel imaging modalities for treatment verification. The development of new detector systems, which can provide an in vivo range assessment or dosimetry, requires an accurate knowledge of the secondary radiation field and reliable Monte Carlo simulations. This paper presents multiple measurements to characterize the prompt γ-ray emissions during proton irradiation and benchmarks the latest Geant4 code against the experimental findings.

View Article and Find Full Text PDF

Proton and ion beams open up new vistas for the curative treatment of tumors, but adequate technologies for monitoring the compliance of dose delivery with treatment plans in real time are still missing. Range assessment, meaning the monitoring of therapy-particle ranges in tissue during dose delivery (treatment), is a continuous challenge considered a key for tapping the full potential of particle therapies. In this context the paper introduces an unconventional concept of range assessment by prompt-gamma timing (PGT), which is based on an elementary physical effect not considered so far: therapy particles penetrating tissue move very fast, but still need a finite transit time--about 1-2 ns in case of protons with a 5-20 cm range--from entering the patient's body until stopping in the target volume.

View Article and Find Full Text PDF

A detector model optimization procedure based on matching Monte Carlo simulations with measurements for two experimentally calibrated sample geometries which are frequently used in radioactivity measurement laboratories results in relative agreement within 5% between simulated and measured efficiencies for a high purity germanium detector. The optimization procedure indicated that the increase in dead layer thickness is largely responsible for a detector efficiency decrease in time. The optimized detector model allows Monte Carlo efficiency calibration for all other samples of which the geometry and bulk composition is known.

View Article and Find Full Text PDF

Therapeutic proton and heavier ion beams generate prompt gamma photons that may escape from the patient. In principle, this allows for real-time, in situ monitoring of the treatment delivery, in particular, the hadron range within the patient, by imaging the emitted prompt gamma rays. Unfortunately, the neutrons simultaneously created with the prompt photons create a background that may obscure the prompt gamma signal.

View Article and Find Full Text PDF

A measurement of the final state distribution of the (8)B β decay, obtained by implanting a (8)B beam in a double-sided silicon strip detector, is reported here. The present spectrum is consistent with a recent independent precise measurement performed by our collaboration at the IGISOL facility, Jyväskylä [O. S.

View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_session7utbpp06ui2bvj28cl71je1lv2dnvdsk): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once